4cyo
From Proteopedia
(Difference between revisions)
m (Protected "4cyo" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4cyo is ON HOLD | + | The entry 4cyo is ON HOLD until Paper Publication |
Authors: Hutton, J.A., Goncalves, V., Brannigan, J.A., Paape, D., Waugh, T., Roberts, S.M., Bell, A.S., Wilkinson, A.J., Smith, D.F., Leatherbarrow, R.J., Tate, E.W. | Authors: Hutton, J.A., Goncalves, V., Brannigan, J.A., Paape, D., Waugh, T., Roberts, S.M., Bell, A.S., Wilkinson, A.J., Smith, D.F., Leatherbarrow, R.J., Tate, E.W. | ||
Description: Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21). | Description: Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21). | ||
Revision as of 07:35, 28 May 2014
Unreleased structure
The entry 4cyo is ON HOLD until Paper Publication
Authors: Hutton, J.A., Goncalves, V., Brannigan, J.A., Paape, D., Waugh, T., Roberts, S.M., Bell, A.S., Wilkinson, A.J., Smith, D.F., Leatherbarrow, R.J., Tate, E.W.
Description: Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21).
